Abstract: Inhalation injury causes a heterogeneous cascade of insults that increase morbidity and mortality among the burn population. Despite major advancements in burn care for the past several decades, there remains a significant burden of disease attributable to inhalation injury. For this reason, effort has been devoted to finding new therapeutic approaches to improve outcomes for patients who sustain inhalation injuries. The three major injury classes are the following: supraglottic, subglottic, and systemic. Treatment options for these three subtypes differ based on the pathophysiologic changes that each one elicits. Currently, no consensus exists for diagnosis or grading of the injury, and there are large variations in treatment worldwide, ranging from observation and conservative management to advanced therapies with nebulization of different pharmacologic agents. The main pathophysiologic change after a subglottic inhalation injury is an increase in the bronchial blood flow. An induced mucosal hyperemia leads to edema, increases mucus secretion and plasma transudation into the airways, disables the mucociliary escalator, and inactivates hypoxic vasocontriction. Collectively, these insults potentiate airway obstruction with casts formed from epithelial debris, fibrin clots, and inspissated mucus, resulting in impaired ventilation. Prompt bronchoscopic diagnosis and multimodal treatment improve outcomes. Despite the lack of globally accepted standard treatments, data exist to support the use of bronchoscopy and suctioning to remove debris, nebulized heparin for fibrin casts, nebulized N-acetylcysteine for mucus casts, and bronchodilators. Systemic effects of inhalation injury occur both indirectly from hypoxia or hypercapnia resulting from loss of pulmonary function and systemic effects of proinflammatory cytokines, as well as directly from metabolic poisons such as carbon monoxide and cyanide. Both present with nonspecific clinical symptoms including cardiovascular collapse. Carbon monoxide intoxication should be treated with oxygen and cyanide with hydroxocobalamin. Inhalation injury remains a great challenge for clinicians and an area of opportunity for scientists. Management of this concomitant injury lags behind other aspects of burn care. More clinical research is required to improve the outcome of inhalation injury. The goal of this review is to comprehensively summarize the diagnoses, treatment options, and current research.
A serious clinical entity, inhalation injury augments morbidity and increases the probability of death. There is a lack of consensus on diagnostic criteria and grading of the severity, and there is no standardized treatment that reduces morbidity and mortality in these patients.
In the United States, 486,000 burn patients received medical treatment in 2016. 1 A total of 3275 died as a result of their injuries. Fire and inhalation casualties are combined in this total; deaths from thermal burns cannot always be distinguished from fatalities resulting from the inhalation of smoke and toxins. The National Burn Repository of the American Burn Association reports up to 10.3% of the burn patients have concomitant inhalation injury. 2, 3 Accordingly, one in ten burn patients surviving to admission will have an inhalation injury with the respective increase in the mortality rate.
Of 40,000 hospital admissions from burn injuries, only 30,000 were at burn centers 2, 3 ; 10,000 patients with burns severe enough to meet hospitalization criteria were treated at nonburn centers. This implies the care received was not specialized-and possibly the treatment was not optimal. Treatment for inhalation injury should be as specialized and as current as possible.
The pulmonary system has the following three fundamental functions: ventilation, oxygenation, and expectoration. The duration of smoke exposure, temperature of the inhaled smoke, and composition of the smoke are determinants of injury severity. 4 Inhalation injury is a composite of multiple insults including the following: supraglottic thermal injury, subglottic airway and alveolar poisoning, and systemic poisoning from absorbed small molecule toxins. These contaminant insults independently affect each of the pulmonary functions as well as have a direct effect on systemic physiology. Furthermore, anatomic characteristics can predispose patients to inhalation injury. For example, an infant will develop airway obstructions much faster than an adult because of reduced airway diameter. Understanding the contributions of each of these pathologies to the patient's disease is critical to managing inhalation injury.
PATHOPHYSIOLOGY Supraglottic
Thermal injury is usually confined to the supraglottis owing to low heat capacity of air and efficient heat dissipation in the upper airway as well as the protective effect of the glottis, which tends to close and prevent heat from reaching the infraglottic area. 5, 6 The edema resulting from injury to the supraglottic structures can obstruct the upper airway just hours after insult. 7 This upper airway edema and obstruction-compromised ventilation can progress quickly with burn edema during resuscitation. 7 
Subglottic
With the exception of inhaled steam, injury below the glottis is largely chemically derived arising from the inhalation of irritants and noxious chemicals, such as halogen acids, unsaturated aldehydes, and formaldehyde, inflicting damage through direct injury as well as through neurogenic inflammation. 8 The materials on fire determine the composition of the smoke and the severity of the inflammatory reactions. These provoke a violent response from the lung parenchyma. The principle subglottic pathophysiologic changes occurring after inhalation injury are the following: airway mucosal hyperemia, bronchospasm, and cast formation from fibrinous exudation into the airways, mucosal sloughing, inspissated mucus, and loss of surfactant and mucociliary escalator function. 7 To start, chemical irritants and smoke entering the lungs incite production of neuropeptides that trigger a major inflammatory response characterized by activation of the vagal nerve sensory C-fibers, which contain proinflammatory peptides, neurokinins, and calcitonin generelated peptide. 9, 10 Neural endopeptidase targets neuropeptides and plays an important role in pathophysiologic changes. 11 This leads to bronchoconstriction and activation of nitric oxide synthase (iNOS), which generates reactive oxygen species and inhibits hypoxic pulmonary vasoconstriction. [12] [13] [14] Increased airway blood flow is the main factor underlying pathologic changes. Dysregulation of hypoxic pulmonary vasoconstriction causes a right-to-left shunting of deoxygenated blood and thus, systemic hypoxemia. Irritation also results in bronchospasm and impairment of gas exchange in distal airways. 7 Edema results as a secondary consequence of the activation of the inflammatory cascade. [15] [16] [17] [18] These pathologies lead to small airway obstruction, including alveoli, and compromise ventilation, leading to ventilation/perfusion (V/Q) mismatching, causing intrapulmonary shunting and, ultimately, compromising oxygenation. Hypermetabolism and the systemic inflammatory response are much more intense when inhalation injury is accompanied by cutaneous burn. 19 Airway mucosal hyperemia begins rapidly after inhalation injury. After inhalation injury, circulation to the right main bronchus increases up to 20-fold. 20 This hyperemia induces some physical narrowing of the airways. More significantly, airway hyperemia promotes edema and airway exudation, which together diminish effective airway space through the formation of fibrin and mucus casts inside the alveoli, compromising oxygenation. Because of augmented bronchial blood flow, microvascular pressure and capillary permeability increase while the plasma protein concentration in the intravascular space decreases. As a result, there is an increase in transvascular fluid flux (lymph flow). 21 The etiology of bronchospasm after inhalation injury is unclear, although it may result from the release of neuropeptides, which are synthesized in the airway submucosa. The degree of spasm depends on the compounds present in the inhaled smoke as well as individual airway sensitivity to the chemical irritants and toxins. [22] [23] [24] [25] The bronchospasm serves to exacerbate the small airway narrowing initiated by airway mucosal hyperemia. This is intensified by the compromised surfactant function that promotes alveolar collapse and atelectasis.
Narrowed airways are ultimately obstructed by airway casts. Airway casts form from blood clots, mucus, and sloughed pulmonary epithelium unable to be expectorated because of impaired mucociliary escalator function. They adhere to the airway wall, reducing luminal space and compromising ventilation. Casts can also obstruct endotracheal cannula. Casts tend to migrate to lower airways because of gravity, and this, combined with impaired ciliary function, produces hypoventilation of the alveoli and shunting, leading to systemic hypoxia. In an inhalation injury animal model, almost 100% of the epithelial airway cells were sloughed within 24 hours after the insult. 26 In addition, the increase in blood flow to the bronchi and consequently to the bronchial mucus glands stimulates mucus secretion. Excessive mucus in the context of impaired ciliary function to clear it leads to the formation of obstructive airway casts and their deleterious effects. 27 Airway obstruction is life-threatening, and even the obstruction of some proximal bronchi can cause hypoventilation of an entire pulmonary segment. 28 Furthermore, the loss of the epithelial integrity in addition to impaired cell function in the airway diminishes bacterial clearance, either through ciliary dysfunction or through impaired phagocytosis. These issues raise the risk of acquiring an infection of the airway and lungs. Failure to expectorate casts and secretions after inhalation injury can be dangerous and lethal by compromising ventilation and causing shunting that embarrasses oxygenation. 29 When casts obstruct areas of the injured lung, tidal volumes redistribute to nonobstructed areas. This injures the nonobstructed, functional lung with volutrauma, barotrauma, acute respiratory distress syndrome (ARDS), and pneumothorax. 30 These additional insults to the airway increase its susceptibility to infections and permit migration of inflammatory cells into the airway, obstructing alveoli and increasing capillary permeability. This cycle leads to further plasma leak and pulmonary edema, impairing the ventilation/oxygenation ratio and creating right-to-left shunting. 31 In addition, casts originate the chain reaction culminating in an intense and generalized inflammation response capable of affecting every organ. 32 Insufficient oxygen in the body is an independent factor for the release of several cytokines that have proinflammatory effects. 33, 34 Proinflammatory mediators and reactive oxygen species, which also result from administration of oxygen in excess of 60% for more than 6 hours, contribute to tissue destruction and organ dysfunction. [35] [36] [37] [38] [39] [40] The small airway obstructions caused by mucosal hyperemia, bronchospasm, epithelial and ciliary loss, and the formation of obstructive casts collectively conspire to compromise ventilation, oxygenation, and expectoration in the subglottic component of inhalation injury.
Acute Respiratory Distress Syndrome
Any discussion of the pathophysiology of subglottic inhalation injury must include ARDS because it is a potentially terminal end point. It typically does not develop until 4 to 8 days after burn. Acute respiratory distress syndrome is the most severe form of acute lung injury that leads to acute respiratory failure and is commonly followed by multisystem organ failure and death. 41 Annually, nearly 200,000 patients are diagnosed with ARDS in the United States, 42 with a mortality rate reaching 36%. 43 Severe burns associate with hypoxemia and the development of ARDS. Clinical manifestations of ARDS include pulmonary edema, inability to ventilate and eliminate carbon dioxide, and marked and severe arterial hypoxemia. If the patient is conscious and not intubated, tachypnea and dyspnea will be prominent. As per the American-European Consensus Conference, the diagnostic criterion was a PaO 2 /FiO 2 ratioof 200 mm Hg or less. 43 The newer Berlin definition characterizes ARDS as acute, within 1 week of a clinical event not explained by cardiac failure, or fluid overload and associated with a positive endexpiratory pressure of 5 cmH 2 0 or greater. Acute respiratory distress syndrome is categorized as mild with a PaO 2 /FiO 2 between 200 and 300, moderate between 100 and 200, and severe less than 100. [44] [45] [46] Inflammation products (eg, cytokines and coagulation system products) are theorized to induce the alterations representative of ARDS. 47 The influx of protein-rich edema fluid into air spaces consequent to increased permeability of the alveolar-capillary barrier and endothelial injury distinguishes the acute phase of ARDS. Intriguingly, it was demonstrated that the severity of inhalation injury does not correlate to the elaboration of ARDS in burned patients. 48 Although the pathology of smoke inhalation begins proximally in the airways and decreases in effect deeper into the lung, the damage in ARDS begins distally in the alveoli and diminishes as it proceeds proximally. Smoke inhalation and ARDS are two distinct but related conditions.
Systemic Injury
The pulmonary damage of an inhalation injury has direct systemic pathophysiology including hypoxemia, hypercapnia, acidosis, and systemic inflammation from the myriad of inflammatory mediators elaborated from the lung. Soluble products of combustion, such as carbon monoxide (CO) and cyanide, serve as direct poisons. CO preferentially binds Fe 2+ in hemoglobin compromising tissue oxygenation.
DIAGNOSIS
No consensus exists regarding the diagnosis, grading, and prognosis of inhalation injury. 49 Lack of diagnostic consensus may result from delayed presentation. Full manifestation occurs up to 48 hours after the inhalation insult once the inflammation reaches its peak. Furthermore, the clinical presentation (degree of respiratory failure) may not correspond with the intensity of the exposure. 50, 51 Acute lung injury can develop in patients who sustain large cutaneous burns without inhalation injury because of the intense and severe inflammatory response extensive burns elicit in burn patients. 52 For instance, patients with a considerable total body surface area (TBSA) burn by scald may develop acute lung injury. 53 Most patients with inhalation injury who arrive early to the emergency department are conscious with a patent airway, and the initial chest radiograph and arterial blood gases may appear at most only slightly abnormal. 54 As a result of nonspecific or delayed presentations, various diagnostic adjuncts are used worldwide.
Findings of a physical examination that can indicate inhalation injury include the following: sooty sputum, stridor, wheezing, facial burns, singed nasal hairs, anxiety, cough, stupor, signs of hypoxemia, and dyspnea. 7, 8, 30, [55] [56] [57] However, physical findings alone can be misleading and should be used in conjunction with other diagnostic adjuncts. One study reported that whereas 70% of inhalation injury patients present with facial burns, 70% of patients with facial burns do not incur significant pulmonary injury. 58 Useful injury history that should be obtained at admission includes estimated time of exposure, type of burning material(s), location of injury (eg, enclosed structure, bonfire), and any changes in mental status. 7 
Supraglottic Injury
Supraglottic injuries are diagnosed on direct visual examination and are often apparent on physical examination. Indirect laryngoscopy permits visual assessment to the level of the vocal cords and can be a useful, albeit limited, tool should bronchoscopy be unavailable to the clinician. 59 Notably, ingesting scalding liquids can produce oropharyngeal scald burns. These may lead to the development of edema that can occlude the airway with fatal consequences, clinically resembling an edematous epiglottitis. 60 
Subglottic Injury
While some clinicians rely on a physical examination and the accident history for diagnosis, these are relatively subjective as compared with bronchoscopy. 51 A diagnostic adjunct for acute inhalation injury since 1975, 61 fiberoptic (flexible) bronchoscopy (FOB) is still not universally available, although it is widely used because it provides an immediate view of the airway and is reliable for making a rapid diagnosis of inhalation injury and grading it. As the criterion standard for diagnosis, FOB permits direct visualization of both supraglottic and subglottic structures and allows assessment of airway tissue damage from temperature or noxious chemical gases. 62 Most importantly, while performing the bronchoscopy, the clinician can decide whether the patient requires intubation. 63 Positive findings of inhalation injury from bronchoscopy include the following: erythema, edema (which may be seen as a blunting of the carina), mucosal blisters, erosions, hemorrhages, bronchial secretions, and soot deposits (Fig. 1) . 7, 8 As Hunt et al 61 noted, the airway may appear normal and show no signs of mucosal injury, particularly when bronchoscopy is performed very early after the inhalation incident. Another factor confounding diagnosis is that extensive cutaneous burns elicit a major inflammatory response. Resultantly, acute lung injury and tracheobronchitis may be seen 48 hours after burn but are unrelated to inhalation injury. Therefore, the physician should supplement the bronchoscopy with physical examination and history of the mechanism of injury to ascertain whether inhalation injury is present. Because of the heat transfer process, greater tissue damage can be expected at proximal sites than at distal ones. 64 Additional diagnostic techniques have been developed and tested; however, these have not been incorporated into standard care protocols because they are too expensive, are not readily available worldwide, or do not provide enough information to justify the cost. Xenon-133 scan is a sensitive tool for the diagnosis of inhalation injury. 58 This useful adjunct can be used to assess the condition of the terminal airways. Various studies have shown that when used in conjunction with FOB or with FOB and pulmonary function tests, diagnoses of inhalation injury were 93% and 96% accurate, respectively. 55, 65 However, as useful abnormal findings often cannot be measured for several hours after injury using this method, the delay required may result in the initiation of treatment too late for optimal management. 59 Gammagram using nebulized technetium-99 has also been used to confirm the diagnosis of inhalation injury. 66 Though highly sensitive, it is not in wide clinical use because of expense, time to acquire the radionuclide, and other logistic difficulties. 67, 68 Another diagnostic adjunct is the chest x-ray. A chest x-ray taken at admission best serves as a baseline for comparison with subsequent ones. A normal chest x-ray on hospital day 1 does not preclude a diagnosis of inhalation injury as pathophysiologic changes may take hours to become apparent in a radiograph. 54 However, pulmonary infiltrates may indicate severe inhalation injury and susceptibility to significant morbidities. 69 Chest tomography (CT) may supplement bronchoscopy as well as be used to grade injury. This adjunct allows the clinician to assess damage to smaller airways. Such damage cannot be assessed by bronchoscopy, which provides views of only the proximal airway. 70 This drawback of FOB has been theorized as an explanation for the discrepancy between mortality and bronchoscopic-determined severity of injury. 57 In assessing the bronchial-wall thickness at admission, one study found that CT measurement significantly correlates to the number of ventilator and intensive care unit (ICU) days and the development of pneumonia. 71 Various approaches have shown utility of a CT scan, but timing of scans and interpretation of findings remain controversial.
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Systemic Poisoning
Systemic injury occurs when toxic compounds such as CO or cyanide are inhaled and enter the blood. Because of nonspecific clinical symptoms, this condition may be dismissed, leading to negative outcomes, including death. Carbon monoxide intoxication can be quickly measured with a pulse CO-oximeter. As a newer diagnostic adjunct, it is not readily available at many centers. Laboratory work can take too long, and delays in transfer as well as supplemental oxygen prophylactically given to patients suspected to have inhalation injury can lower carboxyhemoglobin concentrations. As carboxyhemoglobin levels may not correlate to the degree of poisoning, injury history and physical examinations are vital diagnostic tools in the setting of CO intoxication. Given the half-life of cyanide and no rapid method by which to detect it in the blood, diagnosis of cyanide poisoning largely rests on findings of lactic acidosis and a carboxyhemoglobin concentration of more than 10% as well as abnormal hemodynamics and a Glasgow Coma Scale score of less than 14.
7
GRADING SCHEME
Currently, a multicenter study to determine a grading scheme for inhalation injury based on clinical, bronchoscopic, biochemical, and radiographic findings is underway (ClinicalTrials.gov identifier NCT01194024). Because no such study has transpired before, no consensus exists as to a scoring system. The Abbreviated Injury Score corresponds with an increase in impaired gas exchange and mortality. 73 However, studies have found that the PaO 2 /FiO 2 ratio is a more reliable indicator of inhalation injury severity. However, this grading utility is affected by the ventilator settings, and it may be affected by resuscitation volume. 73, 74 At Shriners Hospitals for Children -Galveston, we grade the severity as mild, moderate, or severe based on bronchoscope findings of erythema, secretion, casts, and epithelial sloughing.
TREATMENT Supraglottic
The primary treatment for a supraglottic inhalation injury compromising the airway is orotracheal or nasotracheal intubation. Most intubations occur before arrival at the burn center by personnel inexperienced in the management of burn patients. 75 Early intubation patients are those who receive supplemental oxygen and present with respiratory distress or hypoxemia or with signs of upper airway compromise, such as mucosal edema, erythema, stridor, or hoarseness.
Data conflict over the appropriateness of early intubation in burn patients. Pulmonary function tests have been investigated for their utility in identifying need for intubation, but the results did not match the clinical status of the patient. 76 In a retrospective study evaluating the efficacy of prehospital intubations, it was shown that of 879 patients, only 11.9% were extubated within 24 hours of admission once inhalation injury was excluded by FOB. 77 In a recent large study series, more than 33% of burn patients were extubated within 1 day of intubation without reintubation after transfer to a burn center. 75 In a smaller series, 53% of burn patients were extubated on hospital day 1 and almost 65% by hospital day 2. 78 Given the many and various complications that can arise from intubations (eg, atelectasis, ventilator-associated pneumonia, lost airway, tracheal injury, death), the risk to the patient may outweigh the reward. 79 In general, intubation is indicated to improve ventilation or oxygenation or to maintain a compromised airway ( Table 1) . The best approach is to keep the airway patent until an experienced practitioner can perform FOB and then determine whether the tube should be removed.
Maintaining an endotracheal tube (ETT) on a burned face is a significant challenge, and accidental extubation is a concern. However, many solutions have been developed. A large survey of American burn centers reported ETTs secured via linen nonadhesive tape in 59% of cases, manufactured devices in 48%, and orthodontic techniques in 24%. 80 Septal ties have been used to secure nasal intubations at Shriners Hospitals for Children -Galveston for 20 years without accidental extubation or septic sinusitis complications. 81 Tracheotomy delivers a durable airway long term with increased patient comfort. The survey of American burn centers also reported the average tracheotomy is performed at 2 weeks. Despite a consensus that indications exist for earlier tracheotomies, 80 Terragni et al 82 found that ventilator and ICU days were reduced but no significant improvement in ventilatorassociated pneumonia from early tracheotomy in a study of 600 adult ICU patients.
When possible, the patient should receive humidified oxygen to prevent secretions from thickening. The head of the bed should be elevated 45 degrees to reduce supraglottic edema and minimize the pressure exerted by the intra-abdominal structures when the patient is lying flat, and judicious use of steroids and/or diuretics may be helpful. 83 
Subglottic
Management of subglottic inhalation injuries is directed at the principle pathophysiologies, particularly mucosal hyperemia and edema, bronchospasm, expectoration of mucous and casts, and improving V/Q ratio. Care must be taken to limit further harm such as ventilator-induced injury through excessive pressure (barotrauma), which may be as severe as a tension pneumothorax and ultimately, life-threatening.
Management of airway hyperemia is currently in preclinical studies. Reduction of airway blood flow through bronchial artery ligation has demonstrated significant improvements in many variables, including reduction in transvascular fluid flux (lymph flow). 19, [84] [85] [86] [87] Studies in animal models of inhalation injury showed that bronchial artery ligation diminishes edema. 19, 88 Occlusion of the bronchial artery reduces chemokine levels. [85] [86] [87] These studies support the use of nebulized agents for treating inhalation injury, especially agents that may reduce edema. Whereas many practitioners endeavor to reduce airway edema by restricting fluid resuscitation, patients with inhalation injury require more intravenous fluid for resuscitation than predicted by resuscitation formulas, 89 which only consider the percent of cutaneous burn. In a preclinical inhalation injury model, fluid restriction exacerbates pulmonary capillary leak and increases lung lymph formation. 90 Fluid restriction can lead to hypoperfusion, shock, and death, whereas fluid overload can result in pulmonary edema, right heart failure, compartment syndromes, shock, and death. 91 Several burn resuscitation formulas can be used to estimate fluid requirements for 24 to 48 hours after burn. The rate of the fluid administration requires titration, which can lead to error and suboptimal outcomes. Resultantly, computerized decision support systems have been developed to assist the burn • Patient safety should not be compromised, and patient status is the ultimate determinant of intubation need • Standard indications for intubation should be followed, including but not limited to shortness of breath, wheezing, stridor, hoarseness, combativeness, or decreased level of consciousness • Contact should be made with the regional burn center as soon as it is safely feasible to discuss the events surrounding the burn and need for intubation • If the patient is clinically stable with no signs or symptoms of compromised airway, burns with lesser need for intubation before transfer to a burn center are as follows: ○Burns that occur from causes other than flame injury ○Burns that do not occur in enclosed spaces ○Burns that are less than 20% TBSA ○Burns that have no third-degree burns to the face ○Patient is within a reasonable distance to a burn center (approximately 3-h transfer time)
surgeon in fluid resuscitation management. In burn patients, these systems have yielded satisfactory results, with sufficient fluid being administered to patients during resuscitation. 92, 93 Regardless of the fluid resuscitation formula used the patient should be resuscitated sufficiently to a selected end point and care taken to avoid fluid overload or underload.
Bronchoalveolar lavage is the washing of lung segments often used to diagnose infections but does have therapeutic relevance, particularly whole-lung lavage. 94, 95 Saline is used to flush the contaminant materials from the lung until the fluid runs clear. 96 In reviewing data from the National Burn Repository, Carr et al 97 determined that burn patients with inhalation injury complicated by pneumonia who underwent at least one bronchoscopic procedure had significantly shorter stays in ICUs and hospitals, reduced hospital costs, and a mortality risk reduced by 18% as compared with burn patients who did not undergo a bronchoscopic procedure. Patients with less than 60% TBSA burn who underwent at least one bronchoscopic procedure had decreased days on mechanical ventilation, leading Carr et al 97 to conclude that bronchoscopy may be indicated after inhalation injury.
Concerningly, airway pressure may rise to dangerous levels if high tidal volume ventilation is initiated; the probability of tension pneumothorax is latent in this scenario. 98 Overdistention of the airway stimulates the release of multiple proinflammatory cytokines such as interleukin 8, a powerful neutrophil chemotactic factor. This results in even greater injury to the pulmonary tissue cells through induction of iNOS. Inducible NOS then serves to increase production of reactive oxygen species, which overpower the native defenses of the body. 57, 99 Therefore, removal of these obstructive casts by medical intervention is vital. However, casts may be lodged in the alveoli, making it difficult or impossible to extract them using mechanical methods such as bronchoalveolar lavage.
Breaking down airway casts and augmenting expectoration comprise the core of managing subglottic inhalation injury. Nebulized fibrinolytics have been evaluated in preclinical inhalation injury models with promising results. 100 Fibrin casts are broken down with nebulized heparin. 101, 102 Heparin prevents coagulation of transudated plasma leaking from injured pulmonary capillaries. 5, 103 With sloughed mucosa, mucus portions of casts are fragmented by N-acetylcysteine acting as a mucolytic agent and permitting expectoration.
104 N-acetylcysteine has been shown safe and efficacious. 105 This combination, nebulized N-acetylcysteine and heparin with albuterol and pulmonary toileting, is a common protocol to treat inhalation injury (Table 2) . 104 It serves to moderate the cell injury incited by iNOS-generated reactive oxygen species. 57 Despite noted methodological issues, a meta-analysis comprising 286 burn patients determined inhaled heparin reduced ventilator days and resulted in more patients alive at day 28 with lower lung injury scores. 106 In a nonburned population, Kashefi et al 107 found an increase in pneumonia rates and no reduction in mortality or mechanical ventilation days from a nebulized heparin and N-acetylcysteine/albuterol regimen, highlighting the distinct pathology of inhalation injury. Conversely, a recently published case-control study of 72 inhalation injured burn patients demonstrated a 7-day course of nebulized heparin with N-acetylcysteine and albuterol increased ventilator-free days and decreased average ventilator days from 14 to 7. There was no increase in mortality, pneumonia rates, or bleeding in this study, and nebulized heparin was found safe and effective. 104 This efficacy is consistent with the clinical experience treating burn patients at Shriners Hospitals for Children -Galveston.
Bronchospasm is treated with nebulized bronchodilators. Nebulized epinephrine has been tested in the preclinical setting with satisfactory results. That is, it reduces airway pressure and increases distensibility through its β2-agonist effects, causing bronchodilation in models of inhalation injury with cutaneous burns. 108 Administration of nebulized albuterol or nebulized epinephrine produces immediate effects, provoking bronchodilation and reducing airway pressure. Bronchodilators are also needed when administering N-acetylcysteine because of its potent respiratory irritant profile.
Injured lungs must clear secretions, damaged mucosa, pathogens, and aspirated material. In the case of compromised mucociliary escalators, transudates of fibrinous material and mucosal slough must be expectorated. Bronchoscopy, mucolytics, suctioning, chest physiotherapy, and specific ventilator modes assist in lung expectoration. 109 Airway suctioning should be performed when needed. If performed incautiously, the patient may become hypoxic and bradycardic because of vagal stimulation. Therefore, preoxygenation is advisable before suction, and suctioning should be performed for up to 10 seconds. Chest physiotherapy, including percussive and coughing techniques, should be performed, along with early mobilization. Postural drainage is recommended and should be performed when possible. 110 Collectively, these techniques prevent the accumulation of secretions, which may cause airway obstruction and atelectasis and potentiate pneumonias. 111, 112 Clearance of secretions can be eased by chest percussion and vibration such as high-frequency chest wall oscillation. 113 Burn patients present considerable challenges in mechanical ventilation and treatment of ARDS because of elevated carbon dioxide production arising from the hypermetabolic response, perturbed physiology from inhalation injury, reduced compliance from eschar, and pulmonary edema from resuscitation. Ventilator management is centered on ensuring sufficient oxygenation and ventilation and optimizing expectoration, balanced against avoiding second-hit injuries that can incite ARDS. ARDSnet studies demonstrated that ventilatorassociated injuries to lungs can trigger ARDS and appreciably affect morbidity and mortality. Although ARDSnet upholds using low tidal volume (LTV), these protocols are ineffectual among burn patients; 33% failed to meet ventilation and oxygenation goals, increasing to approximately 67% with concomitant inhalation injury. 80 Furthermore, the work required to breathe intensifies progressively at LTVs. 114 Investigating pulmonary outcomes in 932 burned pediatric patients with inhalation injury for 28 years, Sousse et al 115 concluded that high tidal volume [15 (3)mL/kg] corresponds with considerably decreased ventilator days and ARDS, maximum positive end-expiratory pressure, significantly increased maximum peak inspiratory pressure, and increased pneumothorax. They determined that high tidal volumes might disrupt the cascade of events leading to lung injury after inhalation injury. 115 Both volume and pressure-cycled modes are in common use, although the optimal ventilator mode in inhalation injury remains controversial. The open lung strategies airway pressure-release ventilation (APRV) and high-frequency percussive ventilation (HFPV) augment impaired oxygenation and buttress expectoration and are becoming the standard modes for more burn centers.
Airway pressure-release ventilation provides unceasing positive airway pressure with a time-cycled pressure-release phase to permit ventilation and expectoration. Keeping pressures elevated in the airways for most of the respiratory cycle, this facilitates improved V/Q ratio, extensive alveolar recruitment permitting an open lung, and very high MAP-O 2 to overpower high A-a gradients. 116 With a time-cycled mode, HFPV delivers subtidal pressurelimited breaths at high frequencies (400-800 beats/min) superimposed on a conventional inspiratory and expiratory pressure-controlled cycle • Nebulize 20% N-acetylcysteine (3 mL) every 4 h for 7 d
• Alternate aerosolizing 10,000 U of heparin (in 3 mL normal saline) every 4 h for 7 d • Nebulize with albuterol in case of wheezing (10-30 breaths/min). This purportedly mobilizes airway secretions and casts, facilitating improved expectoration and pulmonary toilet, and it provides adequate gas exchange at lower airway pressures. First reported in 1989, HFPV has been tested primarily in burned patients with inhalation injury. 117 In this study, HFPV was used as a salvage therapy in one group of burned patients with inhalation injury and as the primary therapy in another group. Improvements in oxygenation and a lower rate of pneumonia were seen. A subsequent study documented an improvement in mortality in burned patients with inhalation injury treated with HFPV compared with historical controls as well as significant decreases in the work of breathing and lower inspiratory pressures in addition to improvements in oxygenation and the rate of pneumonia. 118 However, some studies have reported no statistically significant differences between pressure-limited strategies versus conventional modes in various outcomes (eg, mortality, pulmonary complications, inflammatory markers) except in barotrauma and improved oxygenation. 119, 120 In the trial comparing HFPV with an ARDSnet-based conventional strategy, a lower incidence of barotrauma was seen in the HFPV group, improved oxygenation early and less rescue needed. 120 Although the efficacy is debated, these data mostly support HFPV as a useful adjunct in managing burn patients.
Systemic
Treatment for CO and cyanide intoxication is urgent because these can cause systemic toxicity and can be rapidly fatal. Intoxication should be suspected and ruled out in all patients with intense smoke exposure. When carboxyhemoglobin levels exceed 10%, 100% oxygen should be administered via a tightly fitting high flow mask or endotracheal tube. 121 With 100% oxygen, the half-life of the carboxyhemoglobin was reduced to 74 (25) minutes from 4 to 6 hours. 122, 123 Measurement of carboxyhemoglobin in arterial blood gas can quantify CO quickly. Real-time assessment via pulse CO-oximetry is available but not widely adopted. 124 Controversy exists regarding the use of hyperbaric oxygen in these patients. 125 In addition, hyperbaric chambers are not always available and can be costly. However, in patients whose carboxyhemoglobin levels remain high after administration of oxygen or whose mental status deteriorates, hyperbaric oxygen therapy may be indicated. 126 A 25% reduction in the incidence of long-term neurological sequelae was reported in patients receiving hyperbaric oxygen therapy as compared with patients receiving other treatments. 127 Furthermore, this adjunct has been shown to allay the inflammatory processes provoked by CO poisoning. 126 However, this must be balanced against other critical care needs.
Cyanide is often present in smoke, particularly when the combustible is plastic. Hydroxocobalamin, the precursor of vitamin B12, is a safe treatment with few side effects. Sulfur donors such as sodium thiosulfate accentuate the conversion of cyanide to thiocyanate, reducing its toxicity. 128 However, a task force of the European Centre for Ecotoxicology and Toxicology of Chemicals determined hydroxocobalamin to be the preferred adjunct to treat cyanide intoxication from smoke inhalation rather than sodium thiosulfate or sodium nitrite. 93 Treating cyanide poisoning can be an indirect therapy for CO intoxication because of the synergistic toxicities of the molecules, thereby shortening the duration of oxygen administration.
CONCLUSIONS
Inhalation injuries increase burn mortality through heterogeneous injuries. Limited number of treatment modalities and the lack of a clear diagnostic criteria or grading system to direct therapeutic modalities stymie medical professionals in assessing and managing inhalation injury. This, in turn, has prevented continued significant improvements in the treatment of in this coincident pathology of thermal injury, explaining the high mortality rates resulting from inhalation injury in burn patients. 129 Further clinical study is required to address this grave condition to better serve this patient population.
